reference/16701289

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16701289

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1858
issn	0007-0920 1532-1827
issueIdentifier	11
pageRange	1849-1858
publicationName	British Journal of Cancer
startingPage	1849
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bd6cf90e7346c89132b729ad80507f00
bibliographicCitation	Knight JF, Shepherd CJ, Rizzo S, Brewer D, Jhavar S, Dodson AR, Cooper CS, Eeles R, Falconer A, Kovacs G, Garrett MD, Norman AR, Shipley J, Hudson DL. TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. British Journal of Cancer. 2008 Nov 11;99(11):1849–58. doi: 10.1038/sj.bjc.6604774.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc03304bc39c0b96fcbef4193256101 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a6a8593f3fa70ca90b15a9e22c061b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_594882b6483f8bdb7ae11e3743318849 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84183f5e1ff4062813473907d7fcf7f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7d51ea983798fd204fac61bde32f8c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfe0b0bb74d31a3f0080e7d8d30cff1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df88c1b4055622325829a8c7bc478218 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7fd145fd39ae84f3767db7db8c6d8f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c813fef7df09246026b745c0bda3bc3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fc63a2b3f7668c5c2cebcbb3c3b4742 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdac5dd1b7d8ec57f2401073f7e15c09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daa9e4b341ab821d63c5dd49a1f79546 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cf03c210eb14144c3818e71f6e350d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca731d386e56bbe63433f97211e57766
date	2008-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2600693 https://doi.org/10.1038/sj.bjc.6604774 https://pubmed.ncbi.nlm.nih.gov/19002168
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/1532-1827 https://portal.issn.org/resource/ISSN/0007-0920
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0188097 http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0406100 http://id.nlm.nih.gov/mesh/M0184804 http://id.nlm.nih.gov/mesh/M0015042 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0160138 http://id.nlm.nih.gov/mesh/M000748205
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b1ff6f51e317ad7b29ce8eda413dfff http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a0ac1dcc87f7ea355b59f21bfc1f1b18 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135985134 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID867 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7003 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243214637

Total number of triples: 59.